Singapore markets closed

Vicarious Surgical Inc. (RBOT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
4.1200+0.1600 (+4.04%)
At close: 04:00PM EDT
4.1200 0.00 (0.00%)
After hours: 05:31PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 449.82M
Enterprise value 310.09M
Trailing P/E 35.82
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)3.51
Enterprise value/revenue N/A
Enterprise value/EBITDA 23.62

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-58.34%
S&P500 52-week change 3-1.04%
52-week high 315.7860
52-week low 33.0450
50-day moving average 34.4284
200-day moving average 38.4277

Share statistics

Avg vol (3-month) 3355.16k
Avg vol (10-day) 3257.03k
Shares outstanding 5101.45M
Implied shares outstanding 6N/A
Float 846.36M
% held by insiders 143.87%
% held by institutions 134.97%
Shares short (12 May 2022) 42.14M
Short ratio (12 May 2022) 45.94
Short % of float (12 May 2022) 44.72%
Short % of shares outstanding (12 May 2022) 41.77%
Shares short (prior month 13 Apr 2022) 43.07M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-32.77%
Return on equity (ttm)17.91%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -50.71M
Net income avi to common (ttm)12.55M
Diluted EPS (ttm)0.1140
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)157.01M
Total cash per share (mrq)1.29
Total debt (mrq)17.29M
Total debt/equity (mrq)13.48
Current ratio (mrq)25.17
Book value per share (mrq)1.06

Cash flow statement

Operating cash flow (ttm)-43.92M
Levered free cash flow (ttm)-29.08M